Coleman, Michael F.
McDonell, Shannon B.
Eisenbeis, Lydia K.
Devericks, Emily N.
Chandi, Jobin
Dave, Om
Pearce, Jane B.
Wang, Sylvia
Cody, Morgan
Bustamante-Marin, Ximena M.
Glenny, Elaine M.
Rezeli, Erika T.
Cozzo, Alyssa J.
O’Flanagan, Ciara H.
Bathon, Brooke E.
Shaikh, Saame Raza
Milne, Ginger L.
Wendt, Michael K.
Lanman, Nadia A.
Teegarden, Dorothy
Hursting, Stephen D.
Funding for this research was provided by:
National Cancer Institute (T32LM012420-02, P30CA023168, R01CA271597, R01CA271597, R01CA271597)
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK056350)
Walther Cancer Foundation
Breast Cancer Research Foundation (BCRF-21-073)
University of North Carolina Triple Negative Breast Cancer Center
Article History
Received: 27 May 2025
Accepted: 22 September 2025
First Online: 24 October 2025
Declarations
:
: All in vivo experiments were conducted in accordance with institutional animal care and use committee protocols approved by the University of North Carolina at Chapel Hill (protocol: 16–300).
: Not applicable.
: The authors declare no competing interests.